The ABT-analogous 737, 263, and 199 are other Bcl-2-specific BH3-mimetics active against the subgroup of t(11;14) MM patients presenting a Bcl2high/Mcl-1 low profile [66,67,68]. Here, BCL2 is linked to Miyoshi myopathy.